Zurueck zur Suche

Reporte zur Charge 045-21A

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

7Reporte angezeigt
0Todesfaelle
1Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
CA 2 TN 2 KS 1 NC 1

VAERS 1134364

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 04521A

mild
Staat
CA
Alter
19,0
Geschlecht
F
Eingang
25.03.2021
Impfdatum
19.03.2021
Beginn
20.03.2021
Tage bis Beginn
1,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Rash

Symptomtext

Patient called stating she had a "bad rash" present "all over her body" for one week post vaccination. Scheduled patient with appointment with provider for further evaluation.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Rash
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Onychomycosis
Vorgeschichte
Hyperlipidemia
Andere Medikamente
Terbinafine
Allergien
NKA
Vorherige Impfungen
-

VAERS 2688854

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 04521A

gering
Staat
-
Alter
-
Geschlecht
F
Eingang
29.09.2023
Impfdatum
13.01.2021
Beginn
01.02.2022
Tage bis Beginn
384,0
Dosis
1
Route/Site
- / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
COVID-19 Hot flush Menopausal symptoms SARS-CoV-2 test

Symptomtext

menopause symptoms worse; COVID-19; HOT FLASHES; This spontaneous case was reported by a patient and describes the occurrence of HOT FLUSH (HOT FLASHES), MENOPAUSAL SYMPTOMS (menopause symptoms worse) and COVID-19 (COVID-19) in a female patient of an unknown age who received SPIKEVAX NOS (SPIKEVAX NOS) (batch nos. 04521A, 016/20A and 027/20P) for COVID-19 prophylaxis. Concurrent medical conditions included Blood pressure high and Drug allergy (Unspecified drug). Concomitant products included HYDROCHLOROTHIAZIDE, LOSARTAN POTASSIUM (LOSARTAN/HCTZ) for an unknown indication. On 13-Jan-2021, the patient received third dose of SPIKEVAX NOS (SPIKEVAX NOS) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of SPIKEVAX NOS (SPIKEVAX NOS) (unknown route) 1 dosage form. On an unknown date, received first dose of SPIKEVAX NOS (SPIKEVAX NOS) (unknown route) dosage was changed to 1 dosage form. On 01-Feb-2022, after starting SPIKEVAX NOS (SPIKEVAX NOS), the patient experienced HOT FLUSH (HOT FLASHES). On 24-May-2023, the patient experienced COVID-19 (COVID-19). On an unknown date, the patient experienced MENOPAUSAL SYMPTOMS (menopause symptoms worse). At the time of the report, HOT FLUSH (HOT FLASHES) and MENOPAUSAL SYMPTOMS (menopause symptoms worse) had not resolved and COVID-19 (COVID-19) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 24-May-2023, SARS-CoV-2 test: (Positive) Nasal Swab. Patient received first dose of Moderna vaccine at 03:00 PM. The patient received second dose of Moderna vaccine at 01:00 PM. Patient had hot flashes like patient never had before. Patient sweating so badly so patient makeup runs and hair was constantly feeling oily like patient took a 5-mile run. Patient got period back exactly one month after her second vaccine, Monthly periods lasted for 6 months, then tapered off. Patient menopause symptoms round 2 were significantly worse than menopause round 1. Prior to vaccination, patient not diagnosed with COVID-19. Treatment medications were not reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
COVID-19
Hospital-Tage
-
Labordaten
Test Date: 20230524; Test Name: Baxter; Test Result: Positive
Aktuelle Erkrankungen
Blood pressure high; Drug allergy (Unspecified drug)
Vorgeschichte
-
Andere Medikamente
LOSARTAN/HCTZ
Allergien
-
Vorherige Impfungen
-

VAERS 2513729

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 045-21A

gering
Staat
KS
Alter
85,0
Geschlecht
F
Eingang
21.11.2022
Impfdatum
22.01.2021
Beginn
02.05.2022
Tage bis Beginn
465,0
Dosis
4
Route/Site
IM / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Blood alkaline phosphatase increased Full blood count Immature granulocyte count

Symptomtext

immature granulocytes on CBC on 5/2/2022 and again on 11/7/2022. Alkaline phosphatase 155 on 5/2/2022 and 158 on 11/7/22

Weitere VAERSDATA-Felder
Praegender Schweregrund
Blood alkaline phosphatase increased
Hospital-Tage
-
Labordaten
as above
Aktuelle Erkrankungen
none
Vorgeschichte
Alzheimer's, CKD stage 4, eczema, GERD, hypertension, iron deficiency anemia, osteopenia, type 2 diabetes
Andere Medikamente
baby aspirin atorvastatin, clobetasol lotion, diltiazem donepezil Eliquis, Nexium, Pepcid, Iron Amaryl, Januvia, lisinopril, memantine, fish oil
Allergien
metformin - diarrhea
Vorherige Impfungen
-

VAERS 1501707

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 04521A

gering
Staat
NC
Alter
36,0
Geschlecht
F
Eingang
26.07.2021
Impfdatum
15.04.2021
Beginn
04.05.2021
Tage bis Beginn
19,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Dysmenorrhoea Heavy menstrual bleeding

Symptomtext

After the first shot, I suffered from daily migraines for a week. I took Motrin to help with the migraines. After the second shot, half my body broke out in hives the next day. My doctor prescribed a prescription antihistamine. The hives went away after a few days. A few days after my second vaccine, I got my period. My period lasted for close to a month. My doctor prescribed me Provera to stop my period. Provera finally stopped my period. Starting 12Jul2021 I got my period and now on 26Jul2021, I still have my period with horrible cramps. My period was light in the beginning, but starting 23Jul2021, my period started getting very heavy. I reached out to my doctor to see if I need another round of Provera to stop my period.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dysmenorrhoea
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
No
Vorgeschichte
No
Andere Medikamente
Adderall Zoloft HCTZ Probiotic for gut health Trazadone Tizanadine Requip
Allergien
Wellbutrin-- break out in hives Promethazine-- break out in hives
Vorherige Impfungen
-

VAERS 1238114

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 04521A

gering
Staat
CA
Alter
68,0
Geschlecht
F
Eingang
21.04.2021
Impfdatum
18.03.2021
Beginn
20.04.2021
Tage bis Beginn
33,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
Arteriosclerosis Ascites Biliary dilatation Blood cholesterol normal Blood triglycerides normal Computerised tomogram abdomen abnormal Computerised tomogram pelvis abnormal Hepatic mass High density lipoprotein decreased Low density lipoprotein normal Metastases to peritoneum Non-high-density lipoprotein cholesterol

Symptomtext

The patient presented to the oncology clinic 4/20/21. Owing to worsening ascites (presumed due to hx cholangiocarcinoma) we obtained a same-day CT showing an incidental finding of a extensive multifocal thrombus in the abdominal aorta. Given her history of stroke currently on Plavix, we referred the patient to the ED for inpatient management of this thrombus. She is currently admitted to the hospital and pending evaluation and treatment.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Arteriosclerosis
Hospital-Tage
-
Labordaten
CT Abdomen/Pelvis 4/21/21: IMPRESSION: 1. Similar to slight interval decrease in size of multiple hepatic masses. Suggestion of decreased mass effect with decreased focal biliary ductal dilation to the left hepatic lobe. 2. Similar extent of peritoneal nodularity with increased now moderate volume ascites. 3. Interval development of multifocal, irregular mural thrombi within the abdominal aorta. This puts the patient at risk for distal thromboembolic disease including the lower extremities. Correlate clinically and recommend cardiology and/or vascular surgery consult for management. Results for (MRN) as of 4/21/2021 11:39 4/20/2021 08:19 Cholesterol, Total: 130 Triglycerides, serum: 139 Cholesterol, HDL: 37 LDL Cholesterol: 65 Chol HDL Ratio: 3.5 Non HDL Cholesterol: 93 CT Abdomen/Pelvis 2/26/21 Vasculature: Severe atherosclerotic disease of the abdominal aorta and its branches. IMPRESSION: 1. New peritoneal nodularity and worsening small to moderate volume ascites concerning for peritoneal carcinomatosis. 2. Similar hepatic metastases. CT Abdomen/Pelvis 1/11/21 Vasculature: Moderate atherosclerotic disease of the abdominal aorta and its branches. IMPRESSION: 1. Overall no significant change in the multiple liver lesions when compared to prior. Similar small volume ascites. No definite new sites of disease within the abdomen and pelvis. 2. There is question of soft tissue thickening in the sacral decubitus region. Correlate with clinical examination for signs of decubitus ulcer.
Aktuelle Erkrankungen
Cholangiocarcinoma
Vorgeschichte
hyperlipidemia, hypertension, hypothyroidism, residual dysarthria from prior CVA
Andere Medikamente
Alpha lipoic acid, amlodipine, vitamin C, Lipitor, Alpha lipoic acid, amlodipine, vitamin C, lipitor, cholecalciferol, clopidogrel, maitake mushroom, green tea extract, atorvastatin, flaxseed oil, ozone therapy, lomotil, colace, vibramycin,
Allergien
IV Contrast
Vorherige Impfungen
-

VAERS 1203399

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 04521A

gering
Staat
TN
Alter
51,0
Geschlecht
F
Eingang
13.04.2021
Impfdatum
09.04.2021
Beginn
09.04.2021
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Interchange of vaccine products No adverse event

Symptomtext

Client received Pfizer for dose one and then got Moderna for dose two. No adverse effects reported from client

Weitere VAERSDATA-Felder
Praegender Schweregrund
Interchange of vaccine products
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1186099

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 04521A

gering
Staat
TN
Alter
38,0
Geschlecht
F
Eingang
09.04.2021
Impfdatum
09.04.2021
Beginn
09.04.2021
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Chest discomfort Throat tightness Vital signs measurement

Symptomtext

Client reports waited 15 minutes post vaccine and felt fine, started feeling on heway home that her throat and chest were tight so retuned to vaccination site. Vitals were all normal with O2 at 99%. Administered 100 mg Benadryl IM. All tightness resolved within 15 minutes of receiving Benadryl. Continued to monitor client for 30 minutes, client released to family member with insructions to call 911 for any further complications.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Chest discomfort
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None
Allergien
Bee stings, environmental
Vorherige Impfungen
-